Mucin receptors in chronic rhinosinusitis with nasal polyps


Bedir A., Özgür A., Bakırtaş M., Özdemir D., Mehel D. M., Akgül G., ...More

Acta Oto-Laryngologica, vol.142, no.7-8, pp.585-589, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 142 Issue: 7-8
  • Publication Date: 2022
  • Doi Number: 10.1080/00016489.2022.2116487
  • Journal Name: Acta Oto-Laryngologica
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, International Bibliography of Social Sciences, Biotechnology Research Abstracts, CAB Abstracts, CINAHL, EMBASE, Linguistics & Language Behavior Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.585-589
  • Keywords: chronic sinusitis, mucin receptors, Nasal polyp
  • İstanbul Yeni Yüzyıl University Affiliated: Yes

Abstract

Background: Nasal polyps (NPs) are non-neoplastic, painless inflammatory lesions of the sino-nasal mucosa. Nasal polyp physiopathology is not yet fully understood. There are many potential etiologies of NP, including chronic infections, allergies, asthma, aspirin sensitivity, anatomical disorders, and genetic causes. Objective: The purpose of our study was to immunohistochemically demonstrate the presence of mucin (MUC) receptors in chronic rhinosinusitis (CRS) with nasal polyps and determine the relationships between the presence of these receptors and clinical findings. Material and Methods: A total of 59 patients who underwent functional endoscopic sinus surgery due to CRS with NPs were included in the study. Groups with positive and negative MUC receptors were evaluated according to their clinical characteristics. Results: According to the data we have obtained, surgery site quality and low-dose steroid response worsened with MUC5A receptor positivity and there were no significant relationships between MUC1 receptor positivity and clinical findings. Conclusion: According to our results, MUC5A receptor positivity was associated with impaired surgical site quality and a reduced response to low-dose systemic steroids by NPs.